Impact of SARS-CoV-2 vaccination and booster on COVID-19 symptom severity over time in the COVID-OUT trial.

David R BoulwareThomas A MurrayJennifer L ProperChristopher J TignanelliJohn B BuseDavid M LiebovitzJacinda M NicklasKenneth CohenMichael A PuskarichHrishikesh K BelaniLianne K SiegelNichole R KlattDavid J OddeAmy B KargerNicholas E IngrahamKatrina M HartmanVia RaoAubrey A HagenBarkha PatelSarah L FennoNandini AvulaNeha V ReddySpencer M EricksonSarah LindbergRegina FrictonSamuel LeeAdnin ZamanHanna G SaveraidWalker J TordsenMatthew F PullenNancy E SherwoodJared D HulingCarolyn T Bramantenull null

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)

SARS-CoV-2 vaccine-boosted participants had the least severe symptoms during COVID-19 which abated the quickest over time.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
study protocol
clinical trial
early onset
phase iii
randomized controlled trial
drug induced